G Protein‐Coupled Receptor 17 (Gpr17) Enhances Leptin and Insulin Sensitivity in Lean and Obese Mouse Models

Fuente: Wiley Open Access
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Xun Sun, Connor Mahler, Natalie D. Stull, Ali Nasiri, Baohua Zhou, Varman Samuel, Gerald Shulman, Jonathan N. Flak, Hongxia Ren
Format: Artículo Open Access
Veröffentlicht: Wiley 2026
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1867006896440868864
author Xun Sun
Connor Mahler
Natalie D. Stull
Ali Nasiri
Baohua Zhou
Varman Samuel
Gerald Shulman
Jonathan N. Flak
Hongxia Ren
author_facet Xun Sun
Connor Mahler
Natalie D. Stull
Ali Nasiri
Baohua Zhou
Varman Samuel
Gerald Shulman
Jonathan N. Flak
Hongxia Ren
Xun Sun
Connor Mahler
Natalie D. Stull
Ali Nasiri
Baohua Zhou
Varman Samuel
Gerald Shulman
Jonathan N. Flak
Hongxia Ren
collection Wiley Open Access
contents G Protein‐Coupled Receptor 17 (Gpr17) Enhances Leptin and Insulin Sensitivity in Lean and Obese Mouse Models Xun Sun Connor Mahler Natalie D. Stull Ali Nasiri Baohua Zhou Varman Samuel Gerald Shulman Jonathan N. Flak Hongxia Ren Obesity ABSTRACT Objective Obesity, a major driver for diabetes development, is characterized by insulin and leptin resistance. We previously showed that loss of G protein‐coupled receptor 17 (Gpr17) in specific hypothalamic neurons and the intestine led to better energy balance and glucose metabolism. Our goal is to test whether general loss of Gpr17 enhances insulin and leptin sensitivity. Methods We generated germline Gpr17 knockout mice on both lean ( Gpr17 −/− ) and obese ( Gpr17 −/− ; ob/ob ) backgrounds and characterized their metabolic profile. Results Gpr17 −/− mice exhibited increased energy expenditure and oxygen consumption. Euglycemic‐hyperinsulinemic clamp studies showed enhanced insulin sensitivity in Gpr17 −/− mice with increased glycogen synthesis and decreased glycolysis. Gpr17 −/− ob/ob mice had increased insulin sensitivity with lower baseline serum insulin and higher response to exogenous leptin treatment with more reduction in feeding and increased pStat3 activation in hypothalamic nuclei. Conclusions These findings highlight the inhibitory effect of Gpr17 in leptin and insulin sensitivity, suggesting its potential as a therapeutic target for obesity treatment. image 10.1002/oby.70202 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1002/oby.70202
format Artículo Open Access
id wiley_oa_10_1002_oby_70202
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2026
publisher Wiley
record_format wiley_oa
spellingShingle G Protein‐Coupled Receptor 17 (Gpr17) Enhances Leptin and Insulin Sensitivity in Lean and Obese Mouse Models
Xun Sun
Connor Mahler
Natalie D. Stull
Ali Nasiri
Baohua Zhou
Varman Samuel
Gerald Shulman
Jonathan N. Flak
Hongxia Ren
Obesity
G Protein‐Coupled Receptor 17 (Gpr17) Enhances Leptin and Insulin Sensitivity in Lean and Obese Mouse Models Xun Sun Connor Mahler Natalie D. Stull Ali Nasiri Baohua Zhou Varman Samuel Gerald Shulman Jonathan N. Flak Hongxia Ren Obesity ABSTRACT Objective Obesity, a major driver for diabetes development, is characterized by insulin and leptin resistance. We previously showed that loss of G protein‐coupled receptor 17 (Gpr17) in specific hypothalamic neurons and the intestine led to better energy balance and glucose metabolism. Our goal is to test whether general loss of Gpr17 enhances insulin and leptin sensitivity. Methods We generated germline Gpr17 knockout mice on both lean ( Gpr17 −/− ) and obese ( Gpr17 −/− ; ob/ob ) backgrounds and characterized their metabolic profile. Results Gpr17 −/− mice exhibited increased energy expenditure and oxygen consumption. Euglycemic‐hyperinsulinemic clamp studies showed enhanced insulin sensitivity in Gpr17 −/− mice with increased glycogen synthesis and decreased glycolysis. Gpr17 −/− ob/ob mice had increased insulin sensitivity with lower baseline serum insulin and higher response to exogenous leptin treatment with more reduction in feeding and increased pStat3 activation in hypothalamic nuclei. Conclusions These findings highlight the inhibitory effect of Gpr17 in leptin and insulin sensitivity, suggesting its potential as a therapeutic target for obesity treatment. image 10.1002/oby.70202 http://creativecommons.org/licenses/by/4.0/
title G Protein‐Coupled Receptor 17 (Gpr17) Enhances Leptin and Insulin Sensitivity in Lean and Obese Mouse Models
topic Obesity
url https://onlinelibrary.wiley.com/doi/10.1002/oby.70202